STYLAGE® XL BI-FLEX®

$229.00

/unit
Qty:

Product details

Manufacturer:
Vivacy
Active Substance(s):
CROSS-LINKED HYALURONIC ACID (HA), MANNITOL
Strength:
26mg/g HA
Pack size:
2 x 1ml Pre-Filled Syringes, 2 x 23G Needles, 2 x 27G Needles

Product description

Developed by Laboratoires VIVACY, STYLAGE® XL BI-FLEX® features a cross-linked hyaluronic acid gel formulated using IPN-Like technology. The interpenetrating network contributes to the gel’s cohesivity, while mannitol serves as an antioxidant within the formulation. These properties make the filler suited to restoring facial volume and supporting contours in areas with deeper volume deficits.

Tier

Packs Discount (%) For Each
1 - 5 — $229.00
6 - 10 0.87 % $227.00
11 - 20 1.75 % $225.00
21+ 2.18 % $224.00

Shop with Confidence: 100% Authentic Products

All products are sourced from trusted suppliers and come with original manufacturer LOT numbers for identification and traceability.

Product description

STYLAGE® XL BI-FLEX® is a 26 mg/g cross-linked hyaluronic acid filler from Laboratoires VIVACY, France, formulated with IPN-Like technology and mannitol. Supplied as two 1 mL pre-filled syringes, it helps restore facial volume in the cheeks, chin, jawline, and temples. BI-FLEX® is the updated syringe presentation following BI-SOFT®, not a separate XL gel formulation. Licensed professionals can buy STYLAGE® XL BI-FLEX® online through Doctor Medica after confirming the applicable IFU and local requirements.

Product Specifications

Specification Details
Active ingredients Cross-linked hyaluronic acid (non-animal origin), mannitol
HA concentration 26 mg/g
Lidocaine This presentation does not contain lidocaine. A separate STYLAGE® XL BI-FLEX® with Lidocaine presentation contains 0.3% lidocaine hydrochloride.
Form Monophasic cross-linked HA gel, 2 × 1 mL pre-filled syringes
Technology IPN-Like cross-linking technology
Manufacturer Laboratoires VIVACY, France
Device class CE-marked Class III medical device
FDA status Not FDA-approved for use in the United States
Pack size Two 1 mL pre-filled syringes, two 27G needles, and two 23G needles. Confirm needle lengths and accompanying accessories against the current carton.
Intended area Facial volume restoration and contouring
Injection plane Deep dermis or subcutaneous layer according to the manufacturer’s IFU
Storage Store according to the temperature, light-exposure, and handling instructions in the current product-specific IFU.
Purchase region Europe

Clinics that order STYLAGE® XL BI-FLEX® wholesale should confirm that the delivered presentation, lot details, and accompanying documentation match their purchase records.

Before You Buy STYLAGE® XL BI-FLEX®: Understanding the Product

Within the STYLAGE® portfolio, XL is positioned as a volumizing formulation rather than a product for fine superficial lines. It pairs a comparatively concentrated cross-linked HA with mannitol and is intended for areas where lost structural volume affects facial proportions, principally the cheeks and cheekbones, temples, chin, and broader facial contour. VIVACY describes STYLAGE® XL as intended to restore lost volume and remodel the midface while maintaining smooth projection and tissue integration [3].

BI-FLEX® refers to VIVACY’s updated injection-syringe system, which follows the earlier BI-SOFT® presentation. The newer design incorporates changes to the grip, plunger, and product-identification features to improve handling and injection control [5]. This evolution concerns the delivery system rather than a separate STYLAGE® XL gel formulation. Clinics reviewing older BI-SOFT® records alongside BI-FLEX® listings should verify the product identifier, lidocaine status, and package details for accurate procurement documentation.

STYLAGE® XL is intended for facial volume restoration rather than dedicated lip augmentation. When selecting a STYLAGE® filler for lips, practitioners should choose an appropriately indicated product from the brand’s lip-specific range. Licensed professionals can compare the available formulations and buy STYLAGE® through Doctor Medica after reviewing their respective indications.

Mechanism of Action: IPN-Like Technology, Cross-Linked HA and Mannitol

The behavior of the STYLAGE® XL filler depends on the structure of its cross-linked HA network, not concentration alone. VIVACY’s IPN-Like technology is intended to provide the cohesivity and tissue-support characteristics required for facial volume restoration, while mannitol serves as an antioxidant component [3].

IPN-Like Cross-Linking and Gel Structure

Hyaluronic acid naturally binds water within the extracellular matrix. In a dermal filler, cross-linking modifies the HA network so that it resists enzymatic breakdown longer than unmodified HA and holds a three-dimensional structure after placement. VIVACY describes IPN-Like technology as an interpenetrating-network approach to cross-linked HA, designed to balance cohesivity, projection, and tissue integration [3]. At 26 mg/g of cross-linked HA, XL is a comparatively concentrated volumizer within the STYLAGE® family.

Following injection, the HA matrix retains water and supports the treated tissue. Its cohesivity, elasticity, and resistance to deformation influence how the gel behaves within different anatomical planes. Clinical suitability depends on the gel’s rheological properties, intended indication, and interaction with the surrounding tissue rather than HA concentration alone.

Why STYLAGE® XL Contains Mannitol

Mannitol is incorporated for its antioxidant properties. Laboratory research involving HA viscosupplements used in joint treatment found that mannitol-containing formulations retained their viscoelastic properties more effectively when exposed to oxidative stress [2]. Although this supports a potential protective role for mannitol, the study did not evaluate STYLAGE® XL BI-FLEX® or demonstrate longer-lasting aesthetic outcomes. Clinical duration must therefore be assessed using appropriate filler-specific evidence.

STYLAGE® XL BI-FLEX® Compared With L and XXL

STYLAGE® fillers differ in HA concentration and intended clinical role, and the concentrations do not form a simple linear hierarchy.

Product HA Concentration General Position in the Range
STYLAGE® L BI-FLEX® 24 mg/g Deeper wrinkles and folds, such as nasolabial folds
STYLAGE® XL BI-FLEX® 26 mg/g Midface volume and contour, cheeks, cheekbones, temples, chin
STYLAGE® XXL BI-FLEX® 21 mg/g Pronounced structural volume; a version with 0.3% mepivacaine is available

Although STYLAGE® XXL has a lower listed HA concentration than XL, it is intended for more substantial volume correction. This highlights the importance of considering gel characteristics and manufacturer-specified indications when selecting a formulation. For procurement comparisons, assess STYLAGE® filler cost using equivalent product presentations and pack sizes rather than HA concentration alone.

Practitioners dealing with deeper wrinkles and folds can buy STYLAGE® L BI-FLEX® after confirming the product’s indications and current IFU. The formulation, anesthetic content, and injection plane of any XXL presentation should likewise be checked against its specific documentation.

Indications and Injection Plane for the STYLAGE® XL Filler

The STYLAGE® XL filler is intended for facial volume restoration and contouring in areas such as the cheeks, cheekbones, temples, chin, and facial oval. According to VIVACY, the recommended placement is in the deep dermis or subcutaneous tissue, using techniques appropriate to the treatment area and current IFU [3].

Product selection and administration should account for the patient’s anatomy, tissue characteristics, and required correction. STYLAGE® XL is not intended as a superficial skin-quality filler or as a dedicated lip augmentation product.

When a different formulation is needed, licensed practitioners can compare the available options and buy dermal fillers through Doctor Medica after reviewing their intended indications.

Is STYLAGE® a Good Filler for Volume Restoration? Evidence and Longevity

The strongest product-specific published evidence identified for this review is the BeautyVolume study, a prospective, single-center, uncontrolled post-market study of 40 women aged 30 to 65 [1]. Participants received STYLAGE® XL Lidocaine primarily in the cheekbone area, with optional treatment of the chin, temples, and facial oval. Mean Facial Volume Loss Scale scores improved from 3.1 at baseline to 2.3 at Month 6, a statistically significant change, and clinical improvement remained observable through the 12- and 18-month assessments [1].

The study reported responder rates of approximately 80% at Month 12 and 79.5% at Month 18 under its protocol [1]. These figures should not be read as a guarantee that every patient will retain the same correction for 18 months; the study was small, single-center, and uncontrolled.

Although the BeautyVolume findings support facial volume restoration with STYLAGE® XL Lidocaine, the uncontrolled study design does not establish superiority over other HA fillers or identical outcomes with the lidocaine-free presentation [1].

Safety and Contraindications

Common reactions associated with HA filler treatment include temporary redness, swelling, tenderness, pain, bruising, induration, or localized lumps. In the BeautyVolume study, most treatment-related adverse device effects were mild and consistent with reactions already described in the IFU [1].

Rare but potentially serious complications include unintended vascular injection, vascular occlusion, tissue necrosis, visual disturbance, and, in severe cases, stroke. The FDA advises practitioners using dermal fillers to understand facial vascular anatomy and to have a plan to identify and manage vascular complications [4].

Contraindications and precautions must be checked against the current IFU for the exact presentation. Relevant considerations may include hypersensitivity to formulation components, active infection or inflammation at the injection site, pregnancy-related restrictions, and local-anesthetic hypersensitivity when a lidocaine-containing product is used. As with other HA-based fillers, hyaluronidase may be considered when clinically appropriate, following established management protocols.

Regulatory Checks Before You Buy STYLAGE® XL BI-FLEX®

STYLAGE® XL BI-FLEX® is a CE-marked Class III medical device intended for professional use in applicable European markets [3]. As of November 2026, it is not listed among FDA-approved dermal fillers in the United States [4]. European CE marking does not replace the regulatory authorization required in another jurisdiction.

When buying online, practitioners should confirm that the selected product is eligible for procurement and clinical use in their region. The current IFU, labeling, and applicable local requirements should be reviewed before purchasing.

Practices that order STYLAGE® XL BI-FLEX® online should maintain the applicable IFU and product-traceability documentation. Eligible practitioners can also buy STYLAGE® XL BI-FLEX® wholesale through Doctor Medica and check for wholesale buying options based on their purchasing requirements.

Citations

[1] Mojallal, Ali. “Efficacy and Safety of Stylage XL Lidocaine for the Restoration and/or Augmentation of Facial Volume: The Beauty Volume Study.” Aesthetic Surgery Journal Open Forum, vol. 5, 2023, article ojad056. https://doi.org/10.1093/asjof/ojad056.

[2] Conrozier, Thierry, Pierre Mathieu, and Marguerite Rinaudo. “Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress.” Rheumatology and Therapy, vol. 1, no. 1, 2014, pp. 45–54. https://doi.org/10.1007/s40744-014-0001-8.

[3] Laboratoires VIVACY. “STYLAGE® XL Lidocaine: Remodel Facial Volume & Cheeks.” VIVACY, vivacy.com/en/stylage-hyaluronic-acid-treatment/stylage-xl-lidocaine-facial-remodeling.

[4] U.S. Food and Drug Administration. “FDA-Approved Dermal Fillers.” FDA, https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/fda-approved-dermal-fillers.

[5] Laboratoires VIVACY. “VIVACY Announces the Global Launch of Bi-FLEX® Syringe: A New Generation Injection System Designed for Enhanced Precision and Comfort.” VIVACY, 1 Sept. 2025, https://vivacy.com/en/hyaluronic-acid-injections-latest-research/global-launch-biflex-syringe.


Written by Doctor Medica’s Editorial team

The content on this page has been written and fact-checked in accordance with our Editorial Policy. Clinical claims are sourced from peer-reviewed literature, regulatory documentation, and manufacturer specifications. Where citations are provided, it is always in accordance to our editorial standards.

FAQ

IPN-Like technology refers to VIVACY’s cross-linked HA network architecture, designed to provide cohesivity and support the gel’s volumizing properties. In STYLAGE® XL, these characteristics contribute to its suitability for facial volume restoration rather than superficial line correction.

Mannitol is included for its antioxidant properties. Laboratory research involving HA gels suggests that it may help reduce oxidative degradation, but this does not establish a fixed clinical duration for STYLAGE® XL BI-FLEX® [2].

No. It is CE-marked for authorized European markets but is not currently an FDA-approved dermal filler in the United States.

BI-FLEX® is the newer syringe presentation succeeding BI-SOFT® within the STYLAGE® range. The naming change concerns the delivery system and should not be interpreted as a different XL gel formulation or different intended clinical use. Practitioners should still confirm the exact SKU and whether lidocaine is included.

Published data for STYLAGE® XL Lidocaine showed improvement that remained observable through 18 months in the studied cohort. In practice, duration varies by treatment area, patient, injected volume, and technique.

No. STYLAGE® XL uses non-animal-origin hyaluronic acid produced through bacterial fermentation. The HA is processed and cross-linked to produce the injectable gel used for facial volume restoration.

For licensed medical professionals only. This content is for informational purposes only and does not constitute medical advice.


Doctor Medica sources products exclusively through authorized distributors and established procurement channels. Products are verified as genuine, and supplied in the original packaging with their seal intact. Learn more about how we guarantee product authenticity, sourcing compliance, and traceable delivery to our clients.

Products you may also like

ORTHOVISC 2ML ENGLISH 01
FDA Approved EU Approved
$52.00
HYALGAN 1SYRINGE ENGLISH 01
FDA Approved EU Approved
$49.00
RESTYLANE KYSSE with Lidocaine
FDA Approved EU Approved
$189.00
JUVEDERM VOLUMA LIDOCAINE 2X1ML 01
FDA Approved EU Approved
$359.00
RESTYLANE VOLYME with Lidocaine
EU Approved
$129.00